Supervised injection site: Difference between revisions

Revision as of 21:01, 27 July 2025

Latest revision as of 21:10, 27 August 2025

Line 6:

The geographical distribution of DCRs is uneven, both at the international and regional levels. In 2022, there were over 100 DCRs operating globally, with services in [[Belgium]], [[Denmark]], [[France]], [[Germany]], [[Greece]], [[Luxembourg]], the [[Netherlands]], [[Norway]], [[Portugal]] and [[Spain]], as well as in [[Switzerland]], [[Australia]], [[Canada]], [[Mexico]] and the [[USA]].

Primarily, DCRs aim to prevent drug-related overdose deaths, reduce the acute risks of disease transmission through unhygienic injecting, and connect people who use drugs with addiction treatment and other health and social services. There have been no recorded deaths at any legal supervised injection siesite.<ref name="PBS">{{cite news |last= |first= |date= 9 March 2022 |title= A look inside the 1st official safe injection sites in U.S. |url= https://www.pbs.org/newshour/health/a-look-inside-the-1st-official-safe-injection-sites-in-u-s |work= PBS News |access-date= 5 June 2025}}</ref> They can also aim to minimise public nuisance.<ref>{{Cite news |date=19 December 2023|title=New report presents latest overview on drug consumption rooms in Europe |url= https://www.emcdda.europa.eu/news/2023/new-report-presents-latest-overview-drug-consumption-rooms-europe_en |work= European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) |access-date=22 December 2023}}</ref>

Proponents say they save lives and connect users to services, while opponents believe they promote drug use and attract crime to the community around the site.<ref>{{Cite news |last=Gordon |first=Elana |date=September 7, 2018 |title=What's The Evidence That Supervised Drug Injection Sites Save Lives? |work=[[NPR]] |url=https://www.npr.org/sections/health-shots/2018/09/07/645609248/whats-the-evidence-that-supervised-drug-injection-sites-save-lives}}</ref> Supervised injection sites are part of a [[harm reduction]] approach towards drug problems.